Hypercontractivity on the qq-Araki-Woods algebras

Extending a work of Carlen and Lieb, Biane has obtained the optimal hypercontractivity of the $q$-Ornstein-Uhlenbeck semigroup on the $q$-deformation of the free group algebra. In this note, we look for an extension of this result to the type III situation, that is for the $q$-Araki-Woods algebras. We show that hypercontractivity from $L^p$ to $L^2$ can occur if and only if the generator of the deformation is bounded.Comment: 17 page

SonarKids presenta una activitat video mapping al Parc Tecnològic de Nou Barris

Activitat relacionada amb el festival "Sónar 2016". El festival de música i experiències creatives SonarKids està pensat perquè els nens aprenguin, al costat dels pares i les mares, a gaudir junts de la música, l'art i la tecnologia d'una manera original i interactiva

History of malaria treatment as a predictor of subsequent subclinical parasitaemia: A cross-sectional survey and malaria case records from three villages in Pailin, western Cambodia

Background: Treatment of the sub-clinical reservoir of malaria, which may maintain transmission, could be an important component of elimination strategies. The reliable detection of asymptomatic infections with low levels of parasitaemia requires high-volume quantitative polymerase chain reaction (uPCR), which is impractical to conduct on a large scale. It is unknown to what extent sub-clinical parasitaemias originate from recent or older clinical episodes. This study explored the association between clinical history of malaria and subsequent sub-clinical parasitaemia. Methods: In June 2013 a cross-sectional survey was conducted in three villages in Pailin, western Cambodia. Demographic and epidemiological data and blood samples were collected. Blood was tested for malaria by high-volume qP

The management of acute venous thromboembolism in clinical practice. Results from the European PREFER in VTE Registry

Venous thromboembolism (VTE) is a significant cause of morbidity and mortality in Europe. Data from real-world registries are necessary, as clinical trials do not represent the full spectrum of VTE patients seen in clinical practice. We aimed to document the epidemiology, management and outcomes of VTE using data from a large, observational database. PREFER in VTE was an international, non-interventional disease registry conducted between January 2013 and July 2015 in primary and secondary care across seven European countries. Consecutive patients with acute VTE were documented and followed up over 12 months. PREFER in VTE included 3,455 patients with a mean age of 60.8 ± 17.0 years. Overall, 53.0 % were male. The majority of patients were assessed in the hospital setting as inpatients or outpatients (78.5 %). The diagnosis was deep-vein thrombosis (DVT) in 59.5 % and pulmonary embolism (PE) in 40.5 %. The most common comorbidities were the various types of cardiovascular disease (excluding hypertension; 45.5 %), hypertension (42.3 %) and dyslipidaemia (21.1 %). Following the index VTE, a large proportion of patients received initial therapy with heparin (73.2 %), almost half received a vitamin K antagonist (48.7 %) and nearly a quarter received a DOAC (24.5 %). Almost a quarter of all presentations were for recurrent VTE, with >80 % of previous episodes having occurred more than 12 months prior to baseline. In conclusion, PREFER in VTE has provided contemporary insights into VTE patients and their real-world management, including their baseline characteristics, risk factors, disease history, symptoms and signs, initial therapy and outcomes

Cuentas anuales 2010 de Pro Nou Barris, S.A. (junto con el informe de auditoría)

Formulats pel Consell d'Administració de la Societat de 23-02-2011Podeu consultar la versió en català a: http://hdl.handle.net/11703/106859Informe de gestió de l'exercici 201

Comptes anuals 2010 de Pro Nou Barris, S.A. (juntament amb l’informe de l’auditoria)

Podeu consultar la versió en castellà a: http://hdl.handle.net/11703/107397Informe de gestió de l'exercici 201